Neuberger Berman Group LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Neuberger Berman Group LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$26,772,594
-4.3%
262,613
-5.6%
0.02%
-4.0%
Q2 2023$27,986,146
+1.3%
278,204
-7.5%
0.02%
-3.8%
Q1 2023$27,630,678
-9.4%
300,697
-10.4%
0.03%
-13.3%
Q4 2022$30,482,329
-45.2%
335,450
-54.1%
0.03%
-48.3%
Q3 2022$55,580,000
-19.7%
730,709
-10.8%
0.06%
-17.1%
Q2 2022$69,230,000
-4.0%
818,800
-0.4%
0.07%
+14.8%
Q1 2022$72,146,000
-3.5%
822,183
-5.2%
0.06%
+3.4%
Q4 2021$74,782,000
-10.3%
867,119
-15.2%
0.06%
-19.2%
Q3 2021$83,392,000
-13.9%
1,022,158
-4.2%
0.07%
-14.1%
Q2 2021$96,837,000
-11.3%
1,067,486
-16.4%
0.08%
-18.3%
Q1 2021$109,113,000
-20.5%
1,277,439
-12.2%
0.10%
-26.8%
Q4 2020$137,319,000
-28.4%
1,454,263
-34.0%
0.14%
-37.4%
Q3 2020$191,689,000
-11.9%
2,203,887
-11.6%
0.23%
-15.9%
Q2 2020$217,686,000
+28.2%
2,492,252
+20.9%
0.27%
+4.2%
Q1 2020$169,778,000
-13.9%
2,060,926
-1.1%
0.26%
+12.6%
Q4 2019$197,250,000
+12.3%
2,083,115
+3.1%
0.23%
+7.5%
Q3 2019$175,614,000
-5.5%
2,020,872
-0.7%
0.21%
-3.6%
Q2 2019$185,760,000
+8.1%
2,034,396
+13.9%
0.22%
+5.7%
Q1 2019$171,765,000
+34.0%
1,786,610
+19.6%
0.21%
+17.3%
Q4 2018$128,211,000
+384.0%
1,494,125
+386.0%
0.18%
+496.7%
Q3 2018$26,489,000
+8.4%
307,438
-5.0%
0.03%
+11.1%
Q2 2018$24,441,000
-20.7%
323,553
-15.0%
0.03%
-22.9%
Q1 2018$30,809,000
-4.2%
380,812
-0.6%
0.04%
-5.4%
Q4 2017$32,175,000
+12.8%
383,057
+15.3%
0.04%
+2.8%
Q3 2017$28,518,000
+0.3%
332,179
-2.5%
0.04%
-2.7%
Q2 2017$28,445,000
+5.7%
340,785
-5.9%
0.04%
+5.7%
Q1 2017$26,904,000
-3.9%
362,241
-5.7%
0.04%
-7.9%
Q4 2016$27,984,000
-15.6%
384,184
-8.5%
0.04%
-15.6%
Q3 2016$33,157,000
-11.2%
419,922
-7.2%
0.04%
-11.8%
Q2 2016$37,354,000
+19.3%
452,724
+4.7%
0.05%
+18.6%
Q1 2016$31,310,000
-23.9%
432,215
-9.6%
0.04%
-20.4%
Q4 2015$41,128,000
-1.2%
478,011
+5.6%
0.05%0.0%
Q3 2015$41,622,000
-10.4%
452,803
-4.1%
0.05%
+3.8%
Q2 2015$46,455,000
-45.7%
472,396
-45.5%
0.05%
-42.9%
Q1 2015$85,491,000
-56.8%
866,960
-59.4%
0.09%
-55.6%
Q4 2014$197,705,000
-11.5%
2,133,674
-10.1%
0.20%
-10.5%
Q3 2014$223,345,000
+3.7%
2,372,740
-0.3%
0.23%
+9.0%
Q2 2014$215,465,000
-0.2%
2,380,038
-6.3%
0.21%
-4.5%
Q1 2014$215,903,000
-36.3%
2,539,447
-39.8%
0.22%
-37.0%
Q4 2013$339,203,000
-54.3%
4,219,994
-62.0%
0.35%
-21.6%
Q3 2013$742,769,000
+58.5%
11,105,083
+67.5%
0.44%
-20.1%
Q2 2013$468,684,0006,628,2580.56%
Other shareholders
NOVARTIS A G shareholders Q3 2023
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders